The pharmaceutical grade magnesium sulfate market is projected to grow from USD 199.9 million in 2025 to USD 298.8 million by 2035, at a CAGR of 4.1%. Purity 99% will dominate with a 59.0% market share, while pregnancy-related diseases will lead the application segment with a 38.0% share.